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Background: No case of solitary fibrous tumor of the pleura with Doege-Potter syndrome has been reported in
China. This study was to report a rare repeatedly recurrent case of solitary fibrous tumor of the pleura with
Doege-Potter syndrome diagnosed in China and a three-decade literature review of solitary fibrous tumor of the
pleura with Doege-Potter syndrome worldwide.
Case presentation: A rare case of solitary fibrous tumor of the pleura with Doege-Potter syndrome was diagnosed
in 2005 with follow-up to 2011. All medical records were collected and literature of solitary fibrous tumor of the
pleura with Doege-Potter syndrome from 1979 to 2011 was obtained through Medline. This typical case, diagnosed
and confirmed by histopathologic results, was a 72-year-old Chinese woman who had a complaint of night sweat
for a month. A localized mass 12 cm × 11 cm × 8 cm in size was found associated with pleural effusion in her left
low chest cavity, and blood tests showed severe hypoglycemia. Removal of the mass solved the hypoglycemia. The
case was repeatedly recurrent in April, 2010 and March, 2011 and had no signs of recurrence up to the end of 2011
after surgery. A review of 45 cases of solitary fibrous tumor of the pleura with Doege-Potter syndrome compared
and summarized clinical characteristics, treatments, and outcomes by benign and malignant tumor nature.
Conclusions: Incidence of solitary fibrous tumor of the pleura with Doege-Potter syndrome is similar between
genders. There are no significant differences in clinical characteristics between benign and malignant cases. Surgery is
the first effective treatment for solitary fibrous tumor of the pleura with Doege-Potter syndrome and the completeness
of the initial resection is the key to preventing recurrence. Routine follow-up examinations are recommended for early
detection of recurrence.
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Solitary fibrous tumor of the pleura (SFTP) is a rare pri-
mary tumor, occupying less than 5% of all pleural tu-
mors [1]. It arises from the submesothelial mesenchymal
layer. Hypoglycemia accompanying SFTP is specifically
referred to as the Doege-Potter syndrome (DPS) [2]. A
large form of insulin-like growth factor 2 (IGF-2), which
is probably an incompletely processed molecule of IGF-2,
is derived from the tumor and considered to be a
hypoglycemic mechanism [3]. England reported pathologic* Correspondence: hozhu@jhsph.edu
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reproduction in any medium, provided the ordifferences between benign and malignant SFTP among
141 benign and 82 malignant neoplasms [4] but no sum-
mary of clinical characteristics of benign and malignant
SFTP with DPS due to a small number (n = 12) of DPS
cases. Our report presented a typical case of repeatedly re-
current malignant SFTP with DPS in China, followed from
2005 to 2011. We then reviewed the literature of case
reports of SFTP with DPS from 1979 to 2011 through
Medline, and compared and summarized clinical charac-
teristics, treatments, and outcomes by benign and malig-
nant nature.
Case presentation
A 72-year-old Chinese woman was hospitalized with a
complaint of night sweat for one month in January, 2005.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Summary characteristics of 45 cases of solitary







Age at diagnosis (years): Mean ± SD$ 60.8 ± 10.0 64.1 ± 10.8 0.29
Gender
Male 10 11 0.87
Female 12 12
Sign
Pleural effusion 5 (n = 16) 4 (n = 16) 0.69
Clubbing in fingers 5 (n = 16) 4 (n = 16) 0.69
Skin change 2 (n = 16) 1 (n = 16) 0.54
Tumor mass
Clear borders 13 (n = 13) 16 (n = 20) 0.09
Location
Right 13 (n = 21) 14 (n = 23) 0.94
Left 8 (n = 21) 9 (n = 23) 0.94
Up 1 (n = 17) 2 (n = 20) 0.65
Low 16 (n = 17) 18 (n = 20) 0.65
Size (cm)
≤ 10 0 (n = 17) 1 (n = 21)
>10 17 (n = 17) 20 (n = 21) 0.36
Morphologic Features
Homogeneous 2 (n = 5) 3 (n = 17)
Heterogeneous 3 (n = 5) 14 (n = 17) 0.29
*Pearson P-values for all frequency variables were estimated by individual
Chi-square test and for age at diagnosis by t-test.
$SD: Standard deviation.
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associated with pleural effusion in her left low chest cavity.
Blood tests showed she was severely hypoglycemic. Re-
moval of the mass solved the hypoglycemia. No other
treatments were given. The histopathologic result showed
a solitary fibrous tumor, potentially malignant.
The patient was followed up until April, 2010 when
symptoms of night sweats returned. A physical examin-
ation showed she had no breath sound in the left low
cavity, and the percussion note was dull on the left side
of her thorax. Laboratory evaluation revealed no signifi-
cant abnormalities in hematological or biochemical pro-
file except low blood glucose. The complete resection of
the mass revealed multiple well-capsulated masses in the
left low chest cavity, the largest one 9 cm × 5 cm × 4 cm
in size. Local tumor necrosis and mitosis up to 4/10 high
power fields were microscopically identified. In March,
2011, the patient again had symptoms of night and
morning sweats, and computed tomography and X-ray
revealed a large recurrent tumor mass. The extensive
excision of mass plus extensive excision of the pleura was
performed revealing multiple recurrent parietal pleural
masses in the left low chest cavity, the largest measured
14 cm × 10 cm × 10 cm. The episodes of hypoglycemia
abated postoperatively and the patient seemed in good
health after the surgery and had no signs of recurrence
when we followed her up to the end of 2011.
Literature review
We reviewed the literature in both English and Chinese
languages from 1979 to 2011 through Medline and sum-
marized 45 cases of SFTP with DPS and classified them
into 22 benign and 23 malignant cases based on histopath-
ologic results, referring to the criteria by England et al. [4].
Summary of the 45 cases of SFTP with DPS
Basic characteristics
The age at diagnosis among 22 benign patients ranges
from 38 to 79 years old, with a mean age of 60.8 ± 10.0
(standard deviation) and 23 malignant patients 31 to
79 years with a mean age of 64.1 ± 10.8. Twenty-four
cases (12 benign and 12 malignant) are females and 21
(10 benign and 11 malignant) males. About 86.4% of be-
nign and 87.0% of malignant SFTP patients are diag-
nosed at the ages of 50–70 years old (Table 1).
Clinical characteristics
All patients have hypoglycemia-related symptoms. Ab-
normal consciousness, confusion, and sweating are often
seen in both benign and malignant patients. Signs (such as
pleural effusion, clubbing in fingers, and skin change) are
also seen in both benign and malignant patients (Table 1).
From the 13 benign and 20 malignant reports that
have a detailed description of the tumor mass, 100.0%benign and 80.0% malignant have sharply circumscribed
borders. Most tumors are located in the right low area
of chest cavity. The size of most benign and malignant
tumors is greater than 10 cm. The average dimension of
these SFTPs with DPS is 21.7 ± 5.0 cm for benign and
17.6 ± 4.1 cm for malignant tumors. There is no signifi-
cant difference in morphologic features between benign
and malignant tumors (Table 1).
Treatments and outcomes
Of the 18 benign cases of SFTP with DPS with detailed
surgical information, 13 (72.2%) are removed by simple
excision of mass, and five cases by complex excision that
included adhesion tissue. Of the 20 malignant cases with
detailed surgical information, 11 (55.0%) are removed by
simple excision, and 9 (45.0%) cases by complex excision.
No distant and lymph node metastasis are found in all
cases. The follow-up time in 29 (64.4%) of 45 cases ranges
from 1 to 288 months (average time, 35.3 ± 57.2 months).
All but four (two in benign and two in malignant) of
the patients are free of recurrent SFTP with DPS. One
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rent tumor and adherent tissue). One recurrent tumor is
performed by recurrent tumor excision. But they all are ex-
perienced repeated relapses. The other two patients refuse
medical advice based on poor lung function and other rea-
sons. Radiotherapy and chemotherapy are used in four
malignant cases - two with single radiotherapy and chemo-
therapy but none of them show any effect or benefit. Two
of three cases having detailed information of positron
emission tomography-computed tomography examination
show little to moderate uptake of [14C] fluorodeoxyglucose.
Five of 20 cases given transthoracic needle biopsy could
not get diagnosed, and seven of 20 cases could not be dif-
ferentiated between benign and malignant SFTP due to
limitation of tissue (Table 2).
Discussion
Some criteria, especially England [4], are used worldwide
to distinguish benign from malignant SFTP [5]. The
criteria defined by England et al. [4] include high cellu-
larity, pleomorphism with cytonuclear atypia, more thanTable 2 Treatment and outcome of 45 cases of solitary









Simple excision 13 (n = 18) 11 (n = 20)
Complex excision 5 (n = 18) 9 (n = 20) 0.27
Radiotherapy 0 1 (n = 23)
Chemotherapy 0 1 (n = 23)
Combination therapy
Surgery + radiotherapy 0 2 (n = 23)
Surgery + Chemotherapy 0 0
Surgery + radio + Chemotherapy 0 0
Recurrent 2 (n = 14) 2 (n = 15) 0.94
Imaging features
Lobular borders 6 (n = 11) 9 (n = 15)
Smooth borders 5 (n = 11) 6 (n = 15) 0.78
Pedicle 3 (n = 11) 5 (n = 16) 0.82
Calcification 2 (n = 9) 0
Mass effect on mediastinum 8 (n = 9) 8 (n = 13) 0.16
Atelectasis 8 (n = 9) 7 (n = 9) 0.53
Chest wall involvement 1 (n = 12) 3 (n = 8) 0.11
Results of PET CT$ 2 (n = 3) 0
Benefit of transthoracic needle biopsy 8 (n = 11) 7 (n = 9) 0.80
*Pearson P-values for all frequency variables were estimated by individual
Chi-square test.
$PET CT: positron emission tomography-computed tomography.four mitoses per ten high-power fields, associated necrotic
or hemorrhagic areas. At least 80% of all SFTPs are be-
nign, while the rest may show characteristics of malignant
tumor [2,4,6]. From our study, there are roughly equal
numbers of cases between benign and malignant SFTP
with DPS which is higher than 12-13% of malignancy re-
ported in literature [6]. Gender is nearly evenly distributed
between the benign (12 women and 10 men) and malig-
nant (12 women and 11 men), which is different from the
results reported by England that DPS was three times as
frequent in females as in males [4], probably due to the
small number of DPS cases in his study. Most SFTPs asso-
ciated with DPS are located in the right lower hemithorax,
which is similar to England’s results [4]. The sizes of 100%
benign and 95.2% malignant tumors are > 10 cm, similar
to the conclusion from previous studies [2,4].
Based on the information of 45 cases of SFTP with
DPS in our study, the clinical performances between be-
nign and malignant tumors are almost the same. Local
recurrence can occur in both benign and malignant tu-
mors of SFTP with DPS (two of 14 benign and two of 15
malignant). Surgery is the first effective treatment for
both the original and recurrent benign and malignant
masses [7-9]. These findings are also confirmed by our
case report. Also, we think the completeness of initial
resection is the key to preventing recurrence of SFTP
with DPS. Some recurrent patients may lose the chance
to get re-excision due to unfavorable health condition
after the surgery. For the tumors located in parietal pleura,
complete resection plus extensive excision of the pleura
should be adopted in order to prevent recurrence. It is
noteworthy that four cases (three malignant, one benign)
performed transformation from non-hypoglycemia to
hypoglycemia and one recurrent case performed malig-
nant transformation 25 years after the surgery [10]. Rou-
tine follow-up examinations are recommended for early
detection of recurrent SFTP. Our study also supports the
finding that neither radiotherapy nor chemotherapy has
any effect on the treatment of SFTP with DPS.
Conclusions
Incidence of SFTP with DPS is similar between genders.
There are no significant differences in clinical characteris-
tics between benign and malignant cases. Surgery is the first
effective treatment for SFTP with DPS and the complete-
ness of the initial resection is the key to preventing recur-
rence. Routine follow-up examinations are recommended
for early detection of recurrent SFTP with DPS.
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